OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti(University of Colorado Anschutz Medical Campus), Charles A. Dinarello(University of Colorado Anschutz Medical Campus), Curtis J. Henry(University of Colorado Cancer Center), Sonia Carta(Ospedale Policlinico San Martino), C. Preston Neff(Ospedale Policlinico San Martino), Damaris B. Skouras(Olatec (United States)), Roy D. Altman(Unknown), Veronika Grau(Justus-Liebig-Universität Gießen), Tania Azam(Ospedale Policlinico San Martino), Leo A. B. Joosten(Radboud University Nijmegen), Katrin Richter(Hochschule Bonn-Rhein-Sieg), Curtis L. Scribner(Olatec (United States)), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Robert B. Barrow(Olatec (United States)), Benjamin J. Swartzwelter(Ospedale Policlinico San Martino), Isak W. Tengesdal(Stanford University), Marco Gattorno(Istituto Giannina Gaslini), Joseph P. St. Laurent(EIC Laboratories), Scott A. Goodrich(EIC Laboratories), Anna Rubartelli(Ospedale Policlinico San Martino), Gerald S. Jones(EIC Laboratories), Sabina Janciauskiene(Medizinische Hochschule Hannover), Terry M. Jones(J&S Studies), Fabia Gamboni(Ospedale Policlinico San Martino)
Cited by 556
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway
|EMBO Reports|2002|921